+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Successful Peritoneal Dialysis Using 0.9% Sodium Chloride with Modified M/6 Sodium Lactate Solution and Recycled Catheters


      S. Karger AG

      Peritoneal dialysis, Sodium chloride, Sodium lactate, Dialysis catheter, Dialysate

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Acute peritoneal dialysis (PD) was carried out in 8 patients with renal failure (5 acute, 3 chronic) using 2.076-litre cycles of 0.9% sodium chloride (1,250 ml) plus M/6 sodium lactate (600 ml) to which 5% dextrose (170 ml), 50% dextrose (40 ml) and 10% calcium gluconate (16 ml) were added. Two acute catheters were recycled amongst all the patients after sterilisation in 5% formaldehyde. In all 8 patients, there was progressive clinical and biochemical improvement during 12–88 cycles of PD performed over 0.5–35 days. 2 patients with acute renal failure recovered completely. Another patient had prostatectomy for obstruction and a 4th subsequently received a successful kidney transplant abroad. 3 patients died, 2 of them after discharge from hospital, and 1 defaulted from follow-up. Peritonitis occurred in 2 patients. No side effects attributable to the dialysis solution were observed. However, repeated chemical treatment resulted in catheter opacification and blockage of perforations, but reperforation using a sterile needle usually restored good drainage. In poor countries with limited dialysis facilities, the use of 0.9% sodium chloride with modified M/6 sodium lactate solutions for PD and reuse of acute PD catheters are effective, safe and cost-saving.

          Related collections

          Author and article information

          S. Karger AG
          10 December 2008
          : 53
          : 1
          : 24-26
          Department of Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria
          185696 Nephron 1989;53:24–26
          © 1989 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 3
          Original Paper


          Comment on this article